Enrolling by InvitationN/Aketamine

Comparison of Antinociceptive Effects of Ketamine and Magnesium Used for Sedation in Hysteroscopy Cases

Sponsored by SULEYMAN SARI

NCT ID
NCT06739460
Target Enrollment
120 participants
Start Date
2024-12-10
Est. Completion
2025-01-15

About This Study

This study aims to compare the antinociceptive effects of ketamine and magnesium used in addition to midazolam, fentanyl, propofol and remifentanil agents preferred in hysteroscopy cases. It is conducted to observe the effect of ketamine and magnesium use on total additional propofol doses and additional remifentanil doses.

Conditions Studied

Hysteroscopy

Eligibility

Sex:FEMALE
Age:18 Years - 55 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

1. ASA I-II patients
2. Patients aged 18-55
3. Patients undergoing hysteroscopy

Exclusion Criteria:

1. Patients who develop surgical complications during hysteroscopy
2. Patients with cardiovascular failure (ejection fraction \<40%, patients with atrioventricular conduction disorder
3. Patients with history of cerebrovascular disease
4. Liver dysfunction (transaminases above normal level), Renal failure (creatine \> 150 μmol/L),
5. Preoperative opioid use
6. History of neuromuscular disease
7. History of drug or alcohol abuse
8. Patients who develop the need for endotracheal intubation

Study Locations (1)

Ankara Etlik City Hospital
Ankara, Yenimahalle, Turkey (Türkiye)

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source

Comparison of Antinociceptive Effects of Ketamine and Magnesium Used for Sedation in Hysteroscopy Cases | Huxley